[ad_1]
Advisor OS LLC lifted its holdings in shares of Johnson & Johnson (NYSE:JNJ – Get Ranking) by 28.4% in the course of the second quarter, Holdings Channel.com reviews. The fund owned 13,691 shares of the corporate’s inventory after buying a further 3,026 shares in the course of the interval. Advisor OS LLC’s holdings in Johnson & Johnson had been price $2,430,000 as of its most up-to-date SEC submitting.
A number of different hedge funds have additionally not too long ago modified their holdings of JNJ. Vanguard Group Inc. raised its stake in Johnson & Johnson by 1.4% within the 1st quarter. Vanguard Group Inc. now owns 238,141,110 shares of the corporate’s inventory price $42,205,749,000 after buying a further 3,358,478 shares over the last quarter. GQG Companions LLC lifted its holdings in shares of Johnson & Johnson by 64.4% in the course of the first quarter. GQG Companions LLC now owns 6,501,761 shares of the corporate’s inventory price $1,151,931,000 after buying a further 2,547,378 shares in the course of the interval. Arrowstreet Capital Restricted Partnership boosted its place in Johnson & Johnson by 37.2% within the first quarter. Arrowstreet Capital Restricted Partnership now owns 6,653,610 shares of the corporate’s inventory valued at $1,179,219,000 after shopping for a further 1,805,632 shares over the last quarter. Swiss Nationwide Financial institution raised its place in Johnson & Johnson by 14.0% in the course of the 1st quarter. Swiss Nationwide Financial institution now owns 11,402,516 shares of the corporate’s inventory price $2,020,868,000 after shopping for a further 1,396,500 shares over the last quarter. Lastly, Bridgewater Associates LP lifted its stake in Johnson & Johnson by 40.3% in the course of the 1st quarter. Bridgewater Associates LP now owns 4,345,002 shares of the corporate’s inventory valued at $770,065,000 after buying a further 1,247,260 shares in the course of the interval. Institutional traders and hedge funds personal 68.59% of the corporate’s inventory.
Insider Shopping for and Promoting
In different Johnson & Johnson information, insider William Hait bought 15,000 shares of the agency’s inventory in a transaction that occurred on Monday, October twenty fourth. The shares had been bought at a mean worth of $171.55, for a complete worth of $2,573,250.00. Following the transaction, the insider now instantly owns 80,236 shares of the corporate’s inventory, valued at roughly $13,764,485.80. The transaction was disclosed in a submitting with the Securities & Alternate Fee, which is out there on the SEC web site. In associated information, VP Peter Fasolo bought 29,275 shares of the corporate’s inventory in a transaction dated Monday, October twenty fourth. The shares had been bought at a mean worth of $171.36, for a complete worth of $5,016,564.00. Following the completion of the sale, the vp now owns 114,676 shares of the corporate’s inventory, valued at $19,650,879.36. The sale was disclosed in a authorized submitting with the Securities & Alternate Fee, which is out there on the SEC web site. Additionally, insider William Hait bought 15,000 shares of Johnson & Johnson inventory in a transaction dated Monday, October twenty fourth. The inventory was bought at a mean worth of $171.55, for a complete transaction of $2,573,250.00. Following the transaction, the insider now instantly owns 80,236 shares within the firm, valued at $13,764,485.80. The disclosure for this sale might be discovered right here. Over the past three months, insiders have bought 67,139 shares of firm inventory price $11,350,942. 0.35% of the inventory is owned by insiders.
Analyst Rankings Modifications
A number of analysis companies have commented on JNJ. StockNews.com assumed protection on shares of Johnson & Johnson in a report on Wednesday, October twelfth. They issued a “strong-buy” score on the inventory. SVB Leerink decreased their worth goal on Johnson & Johnson from $200.00 to $194.00 in a analysis report on Wednesday, July twentieth. Barclays initiated protection on Johnson & Johnson in a analysis report on Monday, October seventeenth. They issued an “equal weight” score and a $175.00 worth goal on the inventory. Raymond James reduce their goal worth on shares of Johnson & Johnson from $192.00 to $185.00 and set an “outperform” score for the corporate in a report on Wednesday, October nineteenth. Lastly, Citigroup dropped their worth goal on shares of Johnson & Johnson from $201.00 to $198.00 in a analysis report on Wednesday, October fifth. Six equities analysis analysts have rated the inventory with a maintain score, 5 have issued a purchase score and one has assigned a powerful purchase score to the inventory. In accordance with knowledge from MarketBeat, the corporate presently has a mean score of “Average Purchase” and a consensus goal worth of $184.25.
Johnson & Johnson Inventory Up 1.5 %
JNJ inventory opened at $174.87 on Friday. The inventory has a market capitalization of $459.76 billion, a P/E ratio of 24.36, a P/E/G ratio of three.65 and a beta of 0.56. Johnson & Johnson has a 52 week low of $155.72 and a 52 week excessive of $186.69. The agency has a 50-day easy transferring common of $165.34 and a 200-day easy transferring common of $172.27. The corporate has a fast ratio of 1.17, a present ratio of 1.42 and a debt-to-equity ratio of 0.37.
Johnson & Johnson (NYSE:JNJ – Get Ranking) final introduced its earnings outcomes on Tuesday, October 18th. The corporate reported $2.55 EPS for the quarter, beating analysts’ consensus estimates of $2.49 by $0.06. The enterprise had income of $23.79 billion in the course of the quarter, in comparison with analysts’ expectations of $23.44 billion. Johnson & Johnson had a return on fairness of 35.32% and a internet margin of 19.95%. The enterprise’s income was up 1.9% in comparison with the identical quarter final 12 months. Throughout the identical quarter within the prior 12 months, the agency earned $2.60 earnings per share. Equities analysts forecast that Johnson & Johnson will submit 10.04 earnings per share for the present fiscal 12 months.
Johnson & Johnson introduced that its board has authorized a inventory buyback plan on Wednesday, September 14th that allows the corporate to buyback $5.00 billion in excellent shares. This buyback authorization permits the corporate to reacquire as much as 1.2% of its shares by way of open market purchases. Shares buyback plans are usually a sign that the corporate’s board believes its shares are undervalued.
Johnson & Johnson Declares Dividend
The agency additionally not too long ago introduced a quarterly dividend, which shall be paid on Tuesday, December sixth. Stockholders of document on Tuesday, November twenty second shall be given a $1.13 dividend. This represents a $4.52 dividend on an annualized foundation and a dividend yield of two.58%. The ex-dividend date is Monday, November twenty first. Johnson & Johnson’s dividend payout ratio (DPR) is 62.95%.
Johnson & Johnson Firm Profile
(Get Ranking)
Johnson & Johnson, along with its subsidiaries, researches and develops, manufactures, and sells varied merchandise within the healthcare discipline worldwide. The corporate’s Client Well being section affords child care merchandise underneath the JOHNSON’S and AVEENO Child manufacturers; oral care merchandise underneath the LISTERINE model; pores and skin well being/magnificence merchandise underneath the AVEENO, CLEAN & CLEAR, DR.
See Additionally
Need to see what different hedge funds are holding JNJ? Go to HoldingsChannel.com to get the newest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ – Get Ranking).
Obtain Information & Rankings for Johnson & Johnson Every day – Enter your e mail tackle under to obtain a concise day by day abstract of the newest information and analysts’ rankings for Johnson & Johnson and associated firms with MarketBeat.com’s FREE day by day e mail e-newsletter.
[ad_2]
Source link